Overview

Compare Efficacy and Safety of Repeated Courses of Rituximab to That of Maintenance Mycophenolate Mofetil Following Single Course of Rituximab Among Children With Steroid Dependent Nephrotic Syndrome

Status:
Recruiting

Trial end date:
2021-10-01

Target enrollment:

Participant gender:

Summary

The aim of the RITURNS II study is to evaluate the efficacy and safety of Repeat courses of Rituximab to that of maintenance Mycophenolate Mofetil following single course of Rituximab in maintaining remission over 24 months among Children with Steroid Dependent Nephrotic Syndrome (SDNS).

Phase:

Phase 3

Details

Lead Sponsor:

Nilratan Sircar Medical College

Collaborator:

Heidelberg University

Treatments:

Mycophenolic Acid
Rituximab